Large gap with delayed quotes
|
Last quote
10/24/2025
-
22:15:00
|
Bid
10/24/2025 -
22:00:00
|
Bid Volume |
Ask
10/24/2025 -
22:00:00
|
Ask Volume |
|---|---|---|---|---|
|
51.26
-0.09
(
-0.18% )
|
51.26
|
4,000 |
51.27
|
6,100 |
Analysis date: 24.10.2025
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 03.10.2025.
Interest
Weak
Weak
Two stars since 26.09.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 26.09.2025 at a price of 48.17.
Evaluation
Strongly undervalued
Strongly undervalued
Based on its growth potential and our own criteria, we believe the share price is currently undervalued.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 08.08.2025.
4wk Rel Perf
-0.82%
-0.82%
The four-week dividend-adjusted performance versus SP500 is .
Sensibility
High
High
The stock has been on the high-sensitivity level since 19.11.2024.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by 0.02%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 4.70%.
Mkt Cap in $bn
2.47
2.47
With a market capitalization between $2 & $8bn, HAEMONETICS is considered a mid-cap stock.
G/PE Ratio
1.39
1.39
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
8.41
8.41
The estimated PE is for the year 2028.
LT Growth
9.77%
9.77%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
9
9
Over the last seven weeks, an average of 9 analysts provided earnings per share estimates.
Dividend Yield
1.95%
1.95%
The twelve month estimated dividend yield represents 16.40% of earnings forecasts.
Beta
62
62
For 1% of index variation, the stock varies on average by 0.62%.
Correlation
0.25
0.25
Stock movements are strongly independent of index variations.
Value at Risk
12.31
12.31
The value at risk is estimated at USD 12.31. The risk is therefore 24.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
09.11.2005
09.11.2005